chr11-8413583-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001352389.2(STK33):c.1256C>T(p.Pro419Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000248 in 1,613,908 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P419R) has been classified as Uncertain significance.
Frequency
Consequence
NM_001352389.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
STK33 | NM_001352389.2 | c.1256C>T | p.Pro419Leu | missense_variant | 15/16 | ENST00000687296.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
STK33 | ENST00000687296.1 | c.1256C>T | p.Pro419Leu | missense_variant | 15/16 | NM_001352389.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000855 AC: 13AN: 152016Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000835 AC: 21AN: 251432Hom.: 0 AF XY: 0.0000883 AC XY: 12AN XY: 135888
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1461774Hom.: 0 Cov.: 32 AF XY: 0.0000193 AC XY: 14AN XY: 727190
GnomAD4 genome AF: 0.0000855 AC: 13AN: 152134Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74366
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 21, 2023 | The c.1256C>T (p.P419L) alteration is located in exon 13 (coding exon 11) of the STK33 gene. This alteration results from a C to T substitution at nucleotide position 1256, causing the proline (P) at amino acid position 419 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at